<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02861950</url>
  </required_header>
  <id_info>
    <org_study_id>15-2343</org_study_id>
    <nct_id>NCT02861950</nct_id>
  </id_info>
  <brief_title>Does Caudal Block Increase the Incidence of Urethrocutaneous Fistula Formation Following Hypospadias Repair in Infants?</brief_title>
  <official_title>Does Caudal Block Increase the Incidence of Urethrocutaneous Fistula Formation Following Hypospadias Repair in Infants? A Multi-center Prospective Randomized Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Childrenâ€™s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seattle Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Medical Center Dallas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Mississippi Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of New Mexico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>James Whitcomb Riley Hospital for Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Joe DiMaggio Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's National Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomized multi-center non-inferiority trial conducted through the
      Pediatric Regional Anesthesia Network study sites to determine if caudal block increases the
      incidence of urethrocutaneous fistula following distal or mid shaft hypospadias repair
      compared with penile nerve block.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Small retrospective series are in conflict about whether there is an association between
      caudal block and urethrocutaneous fistulas after hypospadias repair. The most common
      alternative to caudal blockade is a penile nerve block. The investigators will test the
      following hypothesis:

      There is no difference in the incidence of urethrocutaneous fistula formation following
      single stage hypospadias repair with caudal anesthesia compared with penile nerve block.

      The investigators will use a prospective randomized controlled design where subjects will
      receive either a caudal block or a penile nerve block to provide postoperative analgesia.
      Meatal anatomy will be graded by the urologist in the anesthetized child according to the
      HOPE (Hypospadias Objective Penile Evaluation) score, a validated scoring system. Both the
      total score and the individual component scores will be recorded. The operating urologist
      will determine the presence or absence of a fistula at the postoperative visit about 12 weeks
      after surgery, with subsequent follow up at 6 months and again at 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 24, 2017</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of urethrocutaneous fistula</measure>
    <time_frame>1 year</time_frame>
    <description>Presence of a urethrocutaneous fistula at postoperative visit up to 1 year after surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Degree of efficacy of caudal block</measure>
    <time_frame>1 hour after arrival in Post Anesthesia Care Unit (PACU) post surgery</time_frame>
    <description>Blocks will be graded for efficacy using the following scale: Successful, Probably Successful, Probably Failed, or Failed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of pain</measure>
    <time_frame>1 hour after arrival in PACU post surgery</time_frame>
    <description>Patients will have pain scores determined using the modified FLACC score (Face, Legs, Activity, Cry, Consolability) 1 hour after arrival in the PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for supplemental analgesics</measure>
    <time_frame>1 hour after arrival in PACU post surgery</time_frame>
    <description>Administration of opioid in the first postoperative hour will be determined</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">490</enrollment>
  <condition>Hypospadias</condition>
  <condition>Urethrocutaneous Fistula</condition>
  <arm_group>
    <arm_group_label>Caudal block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive a caudal block with 0.75-1ml/kg of 0.2% ropivacaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Penile Nerve Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive a dorsal penile nerve block with up to 0.75ml/kg of 0.25% bupivacaine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caudal block with ropivacaine</intervention_name>
    <description>Patients in this arm will receive a caudal block with ropivacaine</description>
    <arm_group_label>Caudal block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>penile nerve block with bupivacaine</intervention_name>
    <description>Patients in this arm will receive a penile block with bupivacaine</description>
    <arm_group_label>Penile Nerve Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  infants/ children with midshaft or distal hypospadias undergoing primary single stage
             repair in one of the Pediatric Regional Anesthesia Network participating centers.

        Exclusion Criteria:

          -  prior hypospadias surgery,

          -  proximal or penoscrotal hypospadias,

          -  abnormal caudal anatomy or spinal dysraphism,

          -  cyanotic congenital heart disease,

          -  infection or rash at the block injection site.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>4 Months</minimum_age>
    <maximum_age>2 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David M Polaner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David M Polaner, MD</last_name>
    <phone>720-777-6226</phone>
    <email>david.polaner@ucdenver.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vijaya Vemulakonda, MD, JD</last_name>
    <phone>720-777-3926</phone>
    <email>vijaya.vemulakonda@ucdenver.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Polaner, MD</last_name>
    </contact>
    <investigator>
      <last_name>David Polaner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2016</study_first_submitted>
  <study_first_submitted_qc>August 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2016</study_first_posted>
  <last_update_submitted>April 11, 2018</last_update_submitted>
  <last_update_submitted_qc>April 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hypospadias</keyword>
  <keyword>caudal</keyword>
  <keyword>urethrocutaneous fistula</keyword>
  <keyword>penile nerve block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Hypospadias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

